Auro Laboratories Balance Sheet Annual

BSE: 530233 | NSE: - | ISIN: INE292C01011 | Sector: Biotechnology & Drugs

207.40 +7.80 (3.91%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.66	1.79	5.21	10.82
Cash Equivalents	0.99	0.63	7.18	3.71
Short Term Investments	7.11	9.08	7.36	3.77
Cashand Short Term Investments	8.76	11.50	19.76	18.31
Accounts Receivable- Trade Net	13.39	12.40	13.61	7.30
Total Receivables Net	13.39	12.40	13.61	7.30
Total Inventory	8.24	11.76	4.25	2.55
Other Current Assets Total	0.00	0.00	0.00	-
Total Current Assets	30.39	35.66	37.63	28.15
Property/ Plant/ Equipment Total- Net	54.83	20.28	17.28	13.69
Long Term Investments	0.05	0.05	0.05	0.05
Note Receivable- Long Term	0.00	0.00	0.00	0.00
Other Long Term Assets Total	0.00	0.00	-	-
Total Assets	85.27	55.99	54.96	41.89
Accounts Payable	12.03	11.48	4.86	5.75
Notes Payable/ Short Term Debt	7.87	4.40	12.12	0.00
Other Currentliabilities Total	3.57	2.25	3.15	2.72
Total Current Liabilities	23.47	18.13	20.13	8.47
Long Term Debt	18.38	1.76	0.85	2.04
Total Long Term Debt	18.38	1.76	0.85	2.04
Total Debt	26.24	6.16	12.97	2.04
Deferred Income Tax	1.46	1.65	1.65	1.68
Other Liabilities Total	0.00	0.26	0.81	1.12
Total Liabilities	43.31	21.79	23.44	13.31
Common Stock Total	6.23	6.23	6.23	6.23
Retained Earnings( Accumulated Deficit)	35.73	27.97	25.29	22.35
Total Equity	41.96	34.20	31.52	28.58
Total Liabilities Shareholders' Equity	85.27	55.99	54.96	41.89
Total Common Shares Outstanding	0.62	0.62	0.62	0.62
Tangible Book Valueper Share Common Eq	67.32	54.87	50.58	45.86

*All figures in crores except per share values

Trending Stocks

3,753.25+148.70(4.13%)

844.75+28.70(3.52%)

1,784.60+38.65(2.21%)

1,733.95-13.75 (-0.79%)

2,460.60-18.40 (-0.74%)

Related News